Healthy Aging in Dogs: Helping Senior Dogs Live Longer and Better

He is just getting old may be the most quietly costly sentence in dog ownership. Sometimes it is true. It is also the sentence that hides arthritis, heart disease and other treatable things behind a shrug. A 2021 Morris Animal Foundation white paper on ageing pets makes the case that old age is not itself a diagnosis, and that much of what we file under ageing is manageable if someone bothers to name it.

When does a dog become senior?

Less precisely than you would hope. The Foundation's answer is that it depends: you can have a geriatric Great Dane at seven and a Chihuahua going strong into its late teens. Average pet lifespan, it notes, runs anywhere from 8 to 20 years depending on breed. As a working range it puts dogs in senior territory somewhere between five and ten years old, breed-dependent, and says the label should be applied with reference to breed, species and the actual signs of ageing rather than to a birthday.

This is not a small population. The paper counts more than 31 million senior dogs in the United States alone, which is part of why demand for geriatric veterinary medicine has grown so sharply. Its account of the historical shift is striking: small animal practice was largely built around puppies, vaccinations, well-pet checks and the occasional broken bone, and has had to reorganise itself around older patients with chronic conditions.

What actually goes wrong, and how often

• Arthritis: the Foundation estimates that joint arthritis or osteoarthritis affects around one in five adult dogs. The signs it lists are pain, reluctance to move and decreased range of motion.
• Obesity: 56% of dogs in the United States are considered overweight or obese. Extra body fat raises the risk of diabetes, heart disease and joint problems.
• Heart disease: mitral valve disease is the most common heart condition in older small-breed dogs and makes up roughly 75% of the cardiac cases veterinarians see. It is progressive and can lead to heart failure.
• Cancer: pets get cancer at nearly the same rate as people, and prevalence rises as dogs get older.
• Diabetes: affects roughly one in 300 dogs, is common in older animals, and is managed with insulin and modified diets.
• Kidney disease: older dogs are affected, though the condition is around three times more frequent in cats than in dogs.
• Vision: cataracts, glaucoma and progressive retinal atrophy, a degeneration of retinal tissue, are the usual causes of failing sight in older pets.

Read that list next to the just-getting-old sentence and the problem becomes obvious. A dog who has stopped jumping onto the sofa, who takes the stairs one at a time, who is slower on walks and grumpier about being handled, is displaying exactly the arthritis signs the Foundation describes, in a condition it estimates affects one adult dog in five. That is not ageing. That is pain, and pain is treatable.

Older dogs collect problems in clusters

Something the white paper implies, and newer research shows directly, is that conditions in older dogs do not arrive independently. A 2025 analysis in PLOS Computational Biology built the first comorbidity networks for companion dogs, using 26,614 dogs and around 160 health conditions recorded by the Dog Aging Project. Diseases became more interconnected with age: younger dogs' problems are scattered, while senior dogs' conditions cluster around a smaller number of hubs. It also traced sequences, with hip dysplasia tending to precede osteoarthritis and diabetes preceding cataracts, and found the link between hypertension and chronic kidney disease showed up only in the senior group.

The practical translation is that one diagnosis in an older dog is a reason to look more broadly, not to stop looking. It is also an argument for check-ups becoming more frequent as a dog ages. Ask your vet what interval suits your dog's breed, size and history, since a nine-year-old Great Dane and a nine-year-old terrier are not in the same situation.

What research has already changed

The Foundation's own account of what its funding has delivered for older animals is a good reminder that geriatric care has improved quietly rather than dramatically.

• Pain management: research it funded established that one drug widely prescribed to dogs with osteoarthritis is not actually effective, while confirming that other options do provide genuine relief. Worth raising with your vet if your dog's pain plan has gone unreviewed for years.
• Imaging: better imaging now supports earlier diagnosis of heart disease in dogs, and newer techniques for neurological problems have reduced the need for riskier, more invasive testing.
• Nutrition: funded work has led to better therapeutic diets for managing kidney disease in dogs and cats.
• Surgery: drug-releasing lenses have cut the persistent inflammation and eye cloudiness that were major complications of cataract surgery, and funded work has informed pacemaker placement and improved cancer surgery.

What is coming next

The paper's forward-looking section is worth skimming, mostly so you recognise these things when your vet mentions them. Cancer immunotherapies, which stimulate the body's own immune system to attack cancer cells, are being developed for canine osteosarcoma, with the hope of leaning less heavily on surgery, radiation and chemotherapy. Microbiome research is being explored as a non-invasive route into intestinal inflammation, inflammatory bowel disease and obesity.

In regenerative medicine there is one finding with immediate relevance to frail older dogs: for senior animals who cannot safely undergo the general anaesthesia needed to harvest their own stem cells, the Foundation reports that using stem cells from unrelated donors is safe. It also funds something less glamorous and arguably more valuable: independent testing of whether drugs work at all. The Foundation is not backed by drug companies, and describes validating both new and long-used medications as a core role. The arthritis pain finding above is exactly what that looks like.

Furthest out is gene editing. The Foundation has begun funding its first CRISPR studies: one aims to silence a mutation associated with degenerative myelopathy, an incurable and progressive disease of the spinal cord, and another targets a mutation linked to dilated cardiomyopathy, which it describes as the third most frequently diagnosed heart disease in dogs. This is early-stage work and the paper says so.

The point of all this is not longer life at any cost. The Foundation frames its ageing work around quality of life and around managing age-related conditions, not around defeating age itself, and that is the right frame for owners too. The goal for a twelve-year-old dog is not simply another year. It is another year of getting up easily, eating with enthusiasm and still wanting to go out of the front door. Where those things are slipping, the useful question is never is he old, but what specifically is making this harder, and can we do something about it.

This article explains published research and is educational only. It is not a substitute for diagnosis or treatment advice from a licensed veterinarian who has actually examined your dog.